4//SEC Filing
Bonner Michael 4
Accession 0001209191-19-021052
CIK 0001087294other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 5:23 PM ET
Size
6.3 KB
Accession
0001209191-19-021052
Insider Transaction Report
Form 4
Bonner Michael
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2019-03-22$5.62/sh+1,033$5,805→ 19,921 total - Award
Common Stock
2019-03-22$5.98/sh+2,500$14,950→ 20,954 total
Footnotes (2)
- [F1]Restricted stock award will vest 100% on March 18, 2023.
- [F2]This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of shares.
Documents
Issuer
CUMBERLAND PHARMACEUTICALS INC
CIK 0001087294
Entity typeother
Related Parties
1- filerCIK 0001666790
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 5:23 PM ET
- Size
- 6.3 KB